Xenograft models of human neuroblastoma bone metastases.

人神经母细胞瘤骨转移的异种移植模型。

• 批准号: 6800139
• 负责人: CHARLES Patrick REYNOLDS
• 金额: $ 14.88万
• 依托单位: CHILDREN'S HOSPITAL OF LOS ANGELES
• 依托单位国家: 美国
• 财政年份: 2003
• 资助国家: 美国
• 起止时间: 2003-09-10 至 2007-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6800139
• 关键词: SCID mouse; bone neoplasms; cell line; clinical research; disease /disorder model; functional /structural genomics; gene expression; gene expression profiling; histopathology; injection /infusion; metastasis; microarray technology; model design /development; neuroblastoma; phenotype; polymerase chain reaction; radiography; xenotransplantation

DESCRIPTION (provided by applicant): Neurobtastoma is an enigmatic tumor, in which some patients who have widespread disease do well, even with no therapy, while others relentlessly progress, in spite of myeloablative therapy. A key clinical feature associated with bad outcome in neurobtastoma is the presence of bone metastases. In spite of the association of bone metastases with poor outcome in neurobtastoma, and the important contribution that bony disease makes to end-of-life suffering, there have been a paucity of biological studies on neurobtastoma bone metastases, and no clinical tdals. We propose to utilize our large (> 200) panel of human neuroblastoma cell lines to identify cell lines, which readily form metastases in bones of immunocompromised (SCID) mice. We will employ high-resolution small animal radiographic imaging to monitor the animals for bone metastases, and to identify sites for directed histopathology and cell culture at the time of necropsy. We then propose to use Affymetrix otigonucleotide array gene expression profiling in a highly selected panel of cell lines (6 shown to readily form bone metastases and 6 that do not when tested by i.v. injection into SCID mice) to identify genes in which altered expression (especially over-expression) correlates with the ability to form bone metastases in SCID mice. We will select for cells with an increased predilection to form bone metastases by repeated cycles of intravenous injection into SCID mice and harvest and re-culture of cells found growing in bone, and we will compare the selected cell lines to the original parental lines, and to cell lines that do not "home" to bone, using Affymetrix expression profiling. We will confirm a relationship between gene over-expression (or under-expression) and bone metastases in our large panel of cell lines by quantitative RT-PCR for genes identified by expression profiling. RT-PCR will be conducted for all cell lines in the panel known to form or to not form bone metastases, and also will be conducted using xenograft tumors from mouse bone and compared to non-bone metastasizing xenografts grown subcutaneously or in other non-bony sites. This project will provide cell lines and animal models that will be useful for understanding the biology of bone metastases in neuroblastoma, and also for pre-clinical therapeutic studies. We will also identify candidate genes that are key for bone metastases in neuroblastoma. In future studies, beyond the scope of this proposal, we and/or other investigators can determine the ability of the identified candidate genes, when over expressed via transduction, to confer an ability to form bone metastases in SCID mice to cell lines known to rarely form bone metastases. Those candidate genes are likely to be applicable to tumors other than neuroblastoma. We anticipate that this project will increase our understanding of the biology of bone metastases and will develop mouse models for pre-clinical testing of new therapeutic approaches to high risk neuroblastoma.

描述（由申请人提供）： 神经母细胞瘤是一种神秘的肿瘤，一些患有广泛疾病的患者即使没有接受治疗也表现良好，而另一些患者尽管接受了清髓治疗，但仍不断进展。与神经母细胞瘤不良结局相关的一个关键临床特征是骨转移的存在。尽管骨转移与神经母细胞瘤的不良预后相关，并且骨疾病对临终痛苦做出了重要贡献，但对神经母细胞瘤骨转移的生物学研究很少，也没有临床 tdal。我们建议利用我们的大型（> 200）人类神经母细胞瘤细胞系来识别细胞系，这些细胞系很容易在免疫功能低下（SCID）小鼠的骨骼中形成转移。我们将采用高分辨率小动物放射成像来监测动物的骨转移，并在尸检时确定定向组织病理学和细胞培养的部位。然后，我们建议在一组精心挑选的细胞系中使用 Affymetrix 寡核苷酸阵列基因表达谱（6 种显示容易形成骨转移，而 6 种在通过静脉注射到 SCID 小鼠进行测试时则不会）来鉴定表达发生改变的基因（尤其是过表达）与 SCID 小鼠骨转移的能力相关。我们将通过重复循环静脉注射到 SCID 小鼠中并收获和重新培养在骨中发现生长的细胞来选择形成骨转移倾向增加的细胞，并且我们将所选细胞系与原始亲本系进行比较，并且使用 Affymetrix 表达谱分析不“归巢”到骨骼的细胞系。我们将通过对表达谱鉴定的基因进行定量 RT-PCR，确认我们大量细胞系中基因过表达（或表达不足）与骨转移之间的关系。将对组中已知形成或不形成骨转移的所有细胞系进行 RT-PCR，并且还将使用来自小鼠骨的异种移植肿瘤进行 RT-PCR，并与皮下或其他非骨中生长的非骨转移异种移植物进行比较网站。该项目将提供有助于了解神经母细胞瘤骨转移生物学以及临床前治疗研究的细胞系和动物模型。我们还将鉴定对于神经母细胞瘤骨转移至关重要的候选基因。在未来的研究中，超出本提案的范围，我们和/或其他研究人员可以确定已识别的候选基因的能力，当通过转导过度表达时，赋予 SCID 小鼠中已知罕见细胞系形成骨转移的能力形成骨转移。这些候选基因可能适用于神经母细胞瘤以外的肿瘤。我们预计该项目将增进我们对骨转移生物学的理解，并将开发小鼠模型，用于高风险神经母细胞瘤新治疗方法的临床前测试。